Cardioprotective Effects of Soluble Guanylate Cyclase and Its α1 Subunit on Myocardial Ischemia/Reperfusion Injury via the PGC-1α/UCP2 Pathway. [PDF]
Li J +9 more
europepmc +1 more source
The Vasomotor Impact of Cu/ZnSODs Is Higher in Arterial Smooth Muscle of Early Postnatal Rats Compared to Adult Animals. [PDF]
Shvetsova AA +4 more
europepmc +1 more source
Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature. [PDF]
Piroozkhah M +6 more
europepmc +1 more source
Guanylate cyclase activity in moss: revisiting the role of ERECTA-like receptors. [PDF]
Hammer K +5 more
europepmc +1 more source
Trends in Medicare Spending on Drugs for Pulmonary Arterial Hypertension, 2012-2022. [PDF]
Shih JA, Lee C, Feldman WB.
europepmc +1 more source
Avenciguat: a novel soluble guanylate cyclase activator that affects multiple cell types to inhibit IFN-1 signalling and fibrosis. [PDF]
Kaufman J +11 more
europepmc +1 more source
Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models. [PDF]
Sorz-Nechay T +17 more
europepmc +1 more source
Diuretic adherence in patients with pre-capillary pulmonary hypertension: insights from the PHARE study. [PDF]
Le Bozec A +13 more
europepmc +1 more source
Anti-diuretic hormone ITP signals via a guanylate cyclase receptor to modulate systemic homeostasis in <i>Drosophila</i>. [PDF]
Gera J +11 more
europepmc +1 more source
Effects of <i>in vivo</i> treatment with K<sub>v</sub>7.4 activator, URO-K10, on the impaired relaxation of pulmonary arteries in the monocrotaline-induced pulmonary hypertensive rats. [PDF]
Oh SB, Jeon YK, Choi N, Yoo HY, Kim SJ.
europepmc +1 more source

